We are live on
!
Find out more
HCM
Hayman Capital Management Portfolio holdings
AUM
$63.3M
1-Year Est. Return
3.78%
This Fund
S&P 500
This Quarter
Est. Return
+9.43%
1 Year Est. Return
-3.78%
3 Year Est. Return
-44.06%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$126M
AUM Growth
+$81M
(+182%)
Cap. Flow
+$80.3M
Cap. Flow
% of AUM
63.98%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
1
Increased
–
Reduced
1
Closed
1
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NMI Holdings
NMIH
|
+$11.7M |
| 2 |
CLVS
Clovis Oncology, Inc.
CLVS
|
+$1.92M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 23.19% |
| 2 | Energy | 4.92% |
| 3 | Healthcare | 0% |
Similar funds
LVP
PVMCI
SVP
HWM
CCG
CSM
KCP
EL
Hayman Capital Management's Q2 2016 Portfolio in Review
As of Q2 2016, Hayman Capital Management held 4 positions worth $126M, up 182% from $44.6M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Hayman Capital Management deployed $80.3M of net new capital in Q2 2016, opening 1 new position.
By sector, the portfolio is most concentrated in Financials at 23% of assets, down from 84% a quarter earlier, followed by Energy and Healthcare.
On the sell side, the largest reduction was NMI Holdings, an estimated $11.7M trimmed.
- Hayman Capital Management's biggest Q2 2016 reduction was NMI Holdings, cutting an estimated $11.7M.
- Hayman Capital Management fully exited Clovis Oncology, Inc. in Q2 2016, selling an estimated $1.92M.
- Hayman Capital Management's ten largest holdings make up 100% of its $126M portfolio in Q2 2016.
- Hayman Capital Management opened 1 new position and closed 1 in Q2 2016.
- Hayman Capital Management's portfolio value rose 182% quarter-over-quarter to $126M.
Based on Hayman Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.